AI by Google to forecast the actions of the molecular units of living organisms
Introducing the next game-changer in medical research: AlphaFold 3, Google's DeepMind's latest AI model! This model is a massive leap forward, capable of predicting the structure and interactions of all proteins, not just their shapes.
DeepMind, a subsidiary of the Alphabet holding company, explains that AlphaFold 3 goes above and beyond the basic calculations of life's building blocks - proteins. These complex and intricate interactions between proteins and other biomolecules are what really matters in understanding human cell functions and diseases.
The London-based team at Isomorphic Labs, part of DeepMind, has also been instrumental in the development of this game-changing AI model. They specialize in using artificial intelligence for drug research, and their expertise has been a valuable contribution to the project. DeepMind itself is known for developing AlphaFold 2, a software that calculates the three-dimensional shape of proteins.
Understanding the shape and function of proteins is crucial for researchers. This knowledge leads to profound insights into biological processes in the body and can help determine potential causes of diseases. In 2020, DeepMind made headlines with a groundbreaking breakthrough in protein structure predictions, paving the way for discoveries in fields like malaria vaccines, cancer treatments, and enzyme design.
In a recent Nature journal article, DeepMind introduced AlphaFold 3 as a model that raises the bar for predicting the structure and interaction of all life's molecules. The model's accuracy outshines current methods by at least 50%, and in certain important categories, it's twice as accurate.
In addition to this announcement, DeepMind also introduced an AlphaFold server. This free service is open to non-commercial researchers who want to explore AlphaFold 3's capabilities to generate biological structure models. Biologists can easily create large, complex protein structures just by clicking a few times on their screens! The team at Isomorphic Labs is partnering with pharmaceutical companies to harness the potential of AlphaFold 3 for drug development.
Read also:
- Lack of snow also opens up new opportunities for winter tourism
- Abrupt end to e-car subsidies
- The chemical industry has little confidence
- Intersport boss hopes for sales boom through sporting events
Source: www.ntv.de
